Anissa Abi-Dargham, M.D., aa324@columbia.edu PET imaging in different categories of mental illnesses including schizophrenia, addiction, autism, personality and anxiety disorders. Student can be involved in all aspects of the operation, from recruiting to acquiring and analyzing brain scan data.

Efrat Aharnovovich, Ph.D., ea2017@columbia.edu The interplay between clinical neurocognition and treatment outcome and the development and testing of novel therapeutic approaches to the treatment of addictions.  Students will be welcome to actively participate under supervision in clinical and preclinical research procedures.

Paul S. Appelbaum, M.D., psa21@columbia.edu A variety of empirical and theoretical studies of ethical and legal issues in medical treatment and research.  Particular foci include informed consent, decisional capacity, therapeutic misconception, protections for human subjects, voluntariness of consent and related issues.

Evelyn Attia, M.D., ea12@columbia.edu The Eating Disorders Research Unit - Evelyn Attia, Michael B. Devlin, B. Timothy Walsh
This group has a variety of federally funded studies that aim to explore the psychobiology of, and treatment for, anorexia nervosa, bulimia nervosa and binge eating disorder.

Beatrice Beebe, Ph.D., beebebe@pi.cpmc.columbia.edu We do  basic research on mother-infant face to face communication as a function of maternal depression, anxiety, and infant attachment.  We are also running a primary prevention program for mothers who were pregnant and widowed on 9-11 and their young children. 

Joshua Berman M.D. Ph.D., jb481@columbia.edu How stress modulates the effects of nicotine and other psychostimulants on the brain, and on how signals pertaining to affective valence and salience are integrated in basal ganglia and limbic circuits.  Also the effects of stress on psychostimulant related behaviors and effects of psychostimulants on responses to stress in the mouse.

Adam Bisaga, M.D., amb107@columbia.edu 1) Behavioral and cognitive pharmacology of substance abuse, particularly nicotine. 2) Methodology of medication development for substance use disorders, from animal and human laboratory models of disease through early efficacy clinical trials.

Jeffrey Bruce, M.D., jnb2@columbia.edu Translational studies in brain tumors including novel drug delivery systems. progenitor cell biology and tumor immunology.  Correlative clinical studies are ongoing including clinical trials which have evolved from laboratory studies.

Gerard Bruder, Ph.D, bruderg@pi.cpmc.columbia.edu Studies using electrophysiologic (EEG and event-related brain potentials) and behavioral measures to study neurophysiologic, cognitive, and olfactory function in depressive disorders and schizophrenia.

Alex Carballo-Dieguez, Ph.D. ac72@columbia.edu The potential of microbicides for protection in anal intercourse, particularly among men who have sex with men (MSM) and also among women who engage in anal intercourse.  He is also working with partners from the University of Buenos Aires to identify and describe cognitive, socio-cultural and contextual predictors of HIV-related risk behavior; patterns and mediators of HIV testing; and prevalence of HIV among MSM in Argentina.

Carol Caton, Ph.D., clc3@columbia.edu Directs the Columbia Center for Homelessness Prevention Studies (CHPS), an NIMH-funded study focused on the development of interventions to prevent chronic homelessness. Scholars from various departments and schools within Columbia University and providers, consumers, and policy makers throughout the New York City region are involved in this multidisciplinary effort.

Cheryl Corcoran, M.D., cc788@columbia.edu Evaluates teenagers and young adults at heightened clinical risk for psychosis. Research focuses on biomarkers of risk and illness progression, (multimodal imaging, electrophysiology, neuropsychology, endocrine factors), proximal risk factors (drug use and stress), and social function; translational work also occurs in collatoration with basic scientists.

Francine Cournos, M.D., fc15@columbia.edu Clinical opportunities involve working in our inpatient unit or our outpatient clinics in the care of people who have severe mental illnesses such as schizophrenia and bipolar disorder.  Our research is focused in the same population and includes studying the metabolic complications of antipsychotic medications and looking at the efficacy of an HIV prevention for people with severe mental illness in Brazil.

Janis Cutler, M.D., cutlerj@pi.cpmc.columbia.edu The division of Medical Student Education has on-going projects in educational research, including medical student career choice and the impact of various aspects of the psychiatry curriculum on students’ learning and attitudes.

Karina Davidson, PhD, kd2124@columbia.edu Behavioral and psychosocial trials and large cohort studies with hypertensive and/or cardiovascular disease patients.  A randomized, patient preference, persistent depressive symptom trial for acute coronary syndrome patients, anger management for hypertensive patients, and pathophysiological (endothelial dysfunction, platelet aggregation, proinflammatory cytokine production) studies of mental stress and negative affect induction.

Stephen Donovan, M.D., sd45@columbia.edu Treatment of risk factors for the transition from adolescent substance experimentation to substance abuse/dependence.  Treatment of ADHK in the younger siblings of substance abusers: Pilot study of Byvanse (lisdexamfetamine dimesylate) in adolescents (ages 11-15) with ADHD and an older sibling with ADHD and substance dependence.

Alex Dranovsky, M.D., Ph.d., ad722@columbia.edu Inducible genetic manipulations in mice to disrupt circuits that are dysfunctional in psychiatric diseases and study the resulting phenotypes on molecular, cellular and behavioral levels.  We are also interested in identifying novel molecular pathways that are perturbed in psychiatric patients. In a bedside-to-bench approach we are exploring the comorbidity of neoplastic disease and psychiatric syndromes to identify novel molecules involved in depression in patients with pancreatic cancer.

Cristiane S. Duarte, PhD, M.P.H., duartec@childpsych.columbia.edu Understanding child mental health and its relationship with factors of high social impact, particularly childhood obesity.  We are examining the association between child mental health problems and obesity in national and international data sets.  I have a particular interest in minority (particularly Latino) populations.  

Suzette M. Evans, Ph.D., se18@columbia.edu I conduct controlled laboratory research looking at the effects of drugs of abuse in various groups of women. In the context of these studies, we look at stress response and measures of impulsivity. Anyone who volunteers would assist in conducting phone interviews, conducting laboratory sessions and entering data.

Theresa Exner, Ph.D., tmel@columbia.edu We are conducting a large-scale structural intervention promoting use of the female condom in agencies supported by the NYSDOH AIDS Institute.  The unit of intervention is the agency and associated counselors.

Eric A. Fertuck, Ph.D., ef304@columbia.edu Research in the treatment and mechanisms of borderline personality disorder (BPD) and suicide.  We are studying BPD with a social neuroscience approaching using functional neuroimaging and assays of the response of the hypothalamic pituitary axis to stress to better understand the bases of this high risk disorder.

David V. Forrest, M.D., dvforrest@worldnet.att.net Videotaping facial expression in Parkinson's at the Motor Physiology lab to develop computational recognition tools.

David Friedman, Ph.D., df12@columbia.edu The Cognitive Electrophysiology Laboratory employs scalp-recorded event-related brain potentials (ERPs) to understand the neurocognitive processes that underlie mnemonic, attentional and executive functions. Our investigations target childhood development, normal and abnormal aging.

Jill Harkavy Friedman, Ph.D., jmf6@columbia.edu I am involved in a study of suicidal behavior in schizophrenia from biological, neuropsychological, psychosocial and genetic perspectives.

Cathryn Galanter, M.D., cg168@columbia.edu A child and adolescent psychiatrist who does research in the following areas: 1) describing the diagnostic decision making of clinicians, 2) developing tools to improve clinical decision making and 3) the overlap of attention deficit hyperactivity disorder and bipolar disorder in children and adolescents.

James E. Gangwisch, Ph.D., gangwisj@child.cpmc.columbia.edu We have been working on epidemiological studies on the relationship between sleep duration and diseases associated with the metabolic syndrome (obesity, hypertension and diabetes).  I would be happy to have a student work with me on this.

Andrew J. Gerber, MD, Ph.D., gerbera@childpsych.columbia.edu We study social cognition in humans using a functional magnetic resonance imaging paradigm which measures memory performance and affective response to information about new individuals.

Joshua A. Gordon, M.D., Ph.D., jg343@columbia.edu We study genetic models of psychiatric illness from an integrative neuroscience perspective, with a focus on understanding how a given disease mutation leads to a behavioral phenotype in mouse models. To this end, we employ a range of systems neuroscience techniques, including in vivo anesthetized and awake behaving recordings.

Marianne Gorlyn, Ph.D., jg343@columbia.edu Research studies investigating stress arousal differences in response to aggression provocation as a biomarker/risk factor for suicidal behavior in depression.  Students can be involved in recruiting subjects and administering clinical rating scales, a novel laboratory paradigm of aggression induction, physiological response monitoring and a brief neuropsychological test battery.

Madelyn S. Gould, Ph.D., msg5@columbia.edu Youth suicide prevention strategies, primarily through the application of epidemiologic designs.  Our focus has been on the evaluation of prevention, intervention, and postvention programs in schools and in the community.

Deborah Hasin, Ph.D., dsh2@columbia.edu Research on U.S. national aspects of alcohol, drug and psychiatric disorders, DSM-V developments, a gene x environment interaction study in Israel, and drinking-reduction interventions in HIV primary care.  Students would be welcome to analyze existing data, assist with literature reviews and manuscript preparation.

Basalingappa L. Hungund, Ph.D., hungund@nki.rfmh.org The role of endocannabinoid signaling system in many aspects of alcohol-related behaviors.  We use genetic and pharmacological tools to manipulate the endogenous cannabimimetic substances that bind to central cannabinoid CB 1 receptors to understand the neurobiological mechanisms underlying alcohol addiction and to develop drug therapy to treat alcoholism-related medical and behavioral consequences.

Joseph Jaffe M.D., jaffejo@pi.cpmc.columbia.edu Dr. Jaffe seeks an MD or PhD student to assist in simulation studies of psychopathology based on Hidden Markov Chain Models previously published in Science, Nature and Mathematical Biosciences. Math and programming skills are an obvious plus.

Jonathan A. Javitch, M.D., Ph.D., jaj2@columbia.edu Structure and function of G-protein coupled receptors and neurotransmitter transporters, with a particular focus on dopamine receptors and transporter, the targets for antipsychotic drugs and cocaine, respectively.

Alayar Kangarlu, Ph.D., ak2334@columbia.edu We develop tools for MRI to enhance its power in probing the brain more accurately.  We use physics, engineering and computer science techniques to improve quality of various techniques such as high resolution anatomical imaging, diffusion tensor imaging (DTI), FUNCTIONAL (fMRI) and spectroscopy (MRS) for study of the human brain.

Lawrence Kegeles, M.D., Ph.D., lsk5@columbia.edu Current projects are aimed at evaluating neurochemistry including dopamine, GABA and glutamate function in health, in schizophrenia and in other diagnoses.  Studies are done under baseline conditions and in response to brain stimulation and utilize the in vivo imaging modalities of PET and MRS.

David Kimhy, Ph.D., kimhyda@pi.cpmc.columbia.edu Psychosis in Schizophrenia: Mechanisms of Recovery. In particular, the role of stress regulation.  We use a novel methodology to assess in real-time ambulatory stress, autonomic regulation, psychotic symptoms, and coping strategies as part of daily functioning in natural environments. This methodology is used to investigate mechanisms of recovery as part of pharmacological and Cognitive Behavior Therapy for psychosis (CBTp) treatments.

Harry R. Kissileff , Ph.D., hrk2@columbia.edu Eating behavior and physiological measures in patients with eating disorders and normal controls. Volunteers only. Volunteer will help coordinate making of appointments, collecting specialized data, participate in data analysis and prepare preliminary reports.

Robert Klitzman, M.D., rlk2@columbia.edu The impact of the health status of HIV-infected health care workers on communication with and clinical care of patients.  This work led to a study on privacy and disclosure of genetic diseases and another exploring the role of Institutional Review Boards (IRBs) in observing, monitoring and responding to research integrity issues in HIV-related and other areas.

Andreas H. Kottman, Ph.D., ak139@columbia.edu The regulatory mechanisms by which cellular homeostasis in the CNS is maintained throughout life and in the presence of physiological stressors.  The ascending mesencephalic dopaminergic system of genetically altered mice in which we can spatially and temporally control the expression of trophic and cell stress response factors.

Alexis Kuerbis, LCSW, kuerbis@pi.cpmc.columbia.edu A 5-year, NIAAA-funded research program studying treatment options for gay and bixexual men who are interested in moderating their drinking, but who do not wish to stop drinking altogether.  The program combines medication (naltrexone) and specialized, cognitive-behavior psychotherapy provided over 12 weeks, in a 4-group randomized controlled design, and includes research and clinical assessments at 5 time points over the course of 9 months.

Judy Kuriansky, Ph.D., jk2013@columbia.edu  Research projects include US Doctors for Africa initiative, sending doctors and mental health professionals to African countries to work on mobile units to provide services and train locals for capacity; use of radio for AIDS prevention in West Africa; training Chinese doctors in American counseling techniques and sexuality therapy for better patient service delivery.

Johanna Lantz, Ph.D., lantzj@childpsych.columbia.edu I provide behavioral intervention services (primarily applied behavior analysis) and social skills training for individuals with autism and other developmental disabilities of all ages.  I may need volunteers for data collection (live and from videos), for video editing, or to participate as "typical peers" for adolescent and adult social skills groups.

E. David Leonardo, M.D., Ph.D., el367@columbia.edu The role of the ventral hippocampus in mediating anxious and depression related behaviors as well as its possible role in mediating a response to antidepressants.  I am developing transgenic mouse models that allow us to reversibly manipulate the function of hippocampal sub-regions with the aim of studying the behavioral consequences of these manipulations. 

Robert Lewis-Fernandez, M.D., Contact Person, Andel Nicasio, nicasio@pi.cpmc.columbia.edu Work to enhance culturally competent delivery of care, and to strengthen the networks of clinical and social service providers that serve ethnically and linguistically diverse consumers.  The student will work on establishing networds of care that will address the unmet physical health needs of people with severe mental illnesses (SMI).

Sarah H. Lisanby, M.D., slisanby@columbia.edu Brain stimulation research, employing transcranial magnetic stimulation (tms), deep brain stimulation (DBS), electroconvulsive therapy (ECT), magnetic seizure therapy (MST), and other new developments in electromagnetic interventions to study and treat psychiatric and neurological disorders.

Christina Mangurian, M.D., cm2195@columbia.edu Research to improve medical screening of severely mentally ill patients, particularly those taking antipsychotic medications and are at risk of developing the metabolic syndrome.

J. John Mann, M.D., jjm@columbia.edu Functional brain imaging, neurochemistry and molecular genetics to probe the causes of depression and suicide.

Joanne Mantell, Ph.D., jem57@columbia.edu A study of attitudes and practices related to the famale condom among women university students and their male partners in South Africa.  We are conducting additional work in South Africa to develop and test a multi-level structural intervention integrating sexual and reproductive health services into HIV clinical care for HIV-positive adults. 

Rachel Marsh, rm2205@columbia.edu A fMRI study of self-regulatory control in adolescents with Bulimia Nervosa (BN). We are investigating how disturbances in frontostriatal neural systems contribute to the impulsive and habitual binge-eating behaviors in patients with BN.

Diana Martinez, M.D., dm437@columbia.edu PET imaging of substance abuse and addiction  to study the underlying neurochemistry in addiction, with the purpose of improving medication development.

Alice Medalia, Ph.D., am2938@columbia.edu 1) This study examines whether people with schizophrenia learn more when they are intrinsically motivated as opposed to extrinsically motivated, and manipulates the instructional factors that enhance or inhibit learning. 2) This study examines whether people with schizophrenia are more likely to improve working memory if they are given a cognitive remediation approach that directly targets working memory in a noncontextualized task or a cognitive remediation approach that targets working memory as it is activated in a contextualized problem solving activity.

Claude Ann Mellins, Ph.D., cam14@columbia.edu Documenting mental health and HIV risk among HIV-positive children and seroreverters in collaboration with four New York City hospitals.  We are also collaborating on development of a family-based intervention for pre-and early adolescent perinatally HIV-infected youth and their adult caregivers in urban pediatric AIDS clinics in the US and adaptation of this intervention to the South African context.

Heino Meyer-Bahlburg, Dr. rer. nat, meyerb@choldpsych.columbia.edu Understanding the role of biological and social factors in the normal development of gender and sexuality by studying in children, adolexcents and adults the long-term developmental consequences of major prenatal sex-hormone variations due to genetic intersex conditions or to fetal exposure to exogenous hormones for gender-related behavior, gender identity, sexual functioning, and overall quality of life.

Holly Moore, Ph.D., hm2035@columbia.edu Our laboratory uses rodent models to study how abnormal brain development might lead to the abnormalities in neural structure and behavior that are observed in schozophrenia.  We study "candidate pathophysiological mechanisms" that might contribute to the vulnerability for schizophrenia, or the expression of specific symptoms.  We use anatomical, behavioral, neurochemical and neurophysiological techniques to explore brain structure-function abnormalities in these models.

Edward Nunes, M.D., nunesed@pi.cpmc.columbia.edu Clinical trials to study the effectiveness of treatments for drug/alcohol dependence and commonly co-occurring disorders, such as depression, anxiety, PTSD.  We are also correlating clinical outcome with findings from PET imaging. Many of the trials take place in community-based settings.

Maria A. Oquendo, M.D., moquendo@neuron.cpmc.columbia.edu The research clinic focuses on three different topics: mood disorders, alcoholism and suicide. We conduct studies with human subjects to delineate the underlying neurobiology as well as intervention studies to decrease negative outcomes.

Sapana R. Patel, Ph.D., sp2309@columbia.edu The health services research project seeks to understand mental health treatment decision making and develop a decision aid for African American and Latino individuals in primary care practice.  The project involves a pilot study of a mindfulness meditation-based treatment in anxiety disorders.

Tarique. D. Perera. M.D., tp119@columbia.edu The role of newly generated neurons in the mechanism of action of antidepressants.  The work involves histological studies in the neuropathology lab, monkey studies at the non-human primate colony and rat studies at SUNY Downstate, and collaborations at NYSPI, Rockefeller, Yale, Princeton and NIMH.

Angel V. Peterchev, Ph.D., ap2394@columbia.edu Development of electromagnetic brain stimulation technologies and paradigms for basic research and clinical applications. Projects are interdisciplinary, encompassing engineering, neuroscience, and psychiatry.

Bradley Peterson, M.D., PetersoB@childpsych.columbia.edu Pediatric Neuroimaging Laboratory: We combine MRI technologies with genetic, cognitive, and detailed behavioral assessments to understand normal and pathological development of brain structure, function, connectivity, and metabolism in children across a wide range of neuropsychiatric disorders.

Harold Alan Pincus, M.D., pincush@pi.cpmc.columbia.edu 1) Conducting an international survey of country level indicators of quality of mental health care, 2) Implementing and evaluating a quality improvement project to redesign primary care/mental health services among safety net organizations in New Orleans, 3) Conducting key informant interviews with professionals working in aging and mental health to aid in developing a conceptual framework for enhancing pathways for leadership by these professionals in the policymaking arena, 4) Assisting with the design of an instrument and key informant interviews to help evaluate seven interdisciplinary research centers in geriatrics, 5) Assisting in the evaluation of a national program to improve care of depression in primary care, 6) Further developing and piloting an instrument to assess research mentoring at the individual mentor-mentee and institutional levels.

Ning Qian, Ph. D., nq6@columbia.edu Computational and psychophysical studies of stereovision, motion perception, orientation plasticity, facial expressions and motor planning.  

Stephen Rayport, M.D., Ph.D., sgr1@columbia.edu Transgenic approaches to study dopamine and glutamate synaptic transmission in the context of schizophrenia and drug dependence.  Projects focus on dopamine neuron glutamate co-transmission, dopamine receptor trafficking, dopamine neuron morphology and the implications of a genetic reduction of glutamate recycling.  We are also pursuing collaborative postmortem studies on dopamine neuron glutamate co-transmission in man. 

Robert Remien, Ph.D., rhr1@columbia.edu Clinic-based research on prevention and medical adherence for HIV-infected adults.  Studies to explore the social and psychological context of recent HIV transmission and to document acute HIV infection awareness and entry into care among high risk populations using a community-based participatory research model in New York City and Upstate New York communities.  We are extending the work on interventions to promote adherence to HIV treatment to South Africa by adapting and pilot tesitng a media-based intervention that includes social support partners.

John Sahs, M.D., sahsjoh@nyp.org We offer treatment for monolingual Spanish speakers, for individuals with HIV/AIDS, and for English speakers exhibiting a wide variety of psychopathology.  Projects include the evaluation of a manualized treatment for post-traumatic stress disorder in a monolingual Spanish population, the evaluation of a time-limited psychotherapy model used to treat acutely ill patients, or an epidemiological study assessing housing stability in individuals with mental illness.

Stephen A. Sands, Psy.D., ss2341@columbia.edu  Research opportunities in pediatric oncology and bone marrow transplant at Columbia University Medical Center are available and range from assessing Quality of Life for patients and Neuropsychological Late Effects from medical treatment to participating in intervention studies working with parents of newly diagnosed children undergoing medical treatment.

Claudia Schmauss, M.D., cs581@columbia.edu Molecular, anatomic and behavioral studies on animal models of depression-like behaviors and animal models of cognitive dysfunctions to study the role of epigenetic changes in gene expression in psychopathological states.

Franklin Schneier, M.D., frs1@columbia.edu Studies focusing on social and generalized anxiety disorders, including integrating pharmacological and psychotherapeutic treatments, use of fMRI and other imaging techniques, and studying the association of anxiety with general medical disorders. 

Irvin Schonfeld, Ph.D., M.P.H., iss2@columbia.edu Research projects on work, stress and health.  A student who knows a statistical package such as SPSS, MLwiN, Lisrel, etc. could make a contribution.

Harry N. Shair, hns1@columbia.edu Dr. Shair studies the behavioral and neurobiological mechanisms by which the early environment influences current actions and contributes to ontogenetic course of the growing organism. Much of his research focuses on the parent-infant interaction of rats, in particular the formation and expression of early-life social bonds.

Steven A. Siegelbaum, Ph.D., sas8@columbia.edu Our laboratory examines the relationship between hippocampal neural activity and learning and memory. We study mice with a deletion of the HCN1 ion channel gene to determine the neuronal mechanisms underlying the unexpected enhancement in spatial learning and memory observed in these mutant animals.

Richard Sloan, Ph.D., rps7@columbia.edu Psychophysiological studies investigating how psychological and behavioral factors affect autonomic regulation of the heart, which in turn affects development of heart disease; studies include ambulatory monitoring of autonomic reactivity to “everyday life” stressors, as well as laboratory-based protocols. Second, we study interferon-alpha induced depression syndrome. We have a PET brain imaging study and a clinical trial using an SSRI prophylactically to investigate mechanisms of medical patients treated with interferon-alpha, who experience very prevalent depression-like symptoms.

Nomita Sonty, Ph.D., ns331@columbia.edu Exploration of protective factors impacting disability in patients with chronic pain, the use of TENS to predict tolerance to paresthesias in patients undergoing spinal cord stimulator implantation and physician socio-demographic factors interacting with patient socio-demographic factors to influence treatment recommendations.

Arielle D. Stanford, M.D., as1019@columbia.edu I study the pathophysiology of the negative symptoms of schizophrenia using transcranial magnetic stimulation in combination with various imaging and electrophysiological techniques. This work will lead to the optimization of novel non-invasive brain stimulation treatments for these symptoms.

Barbara Stanley, Ph.D., bstanley@neuron.cpmc.columbia.edu Our group conducts research in two areas: 1) biobehavioral, clinical and neuroimaging research on borderline personality disorder, suicidal behavior and non-suicidal self injury such as superficial cutting; and 2) development and testing of interventions for individuals at risk for suicide.

Jonathan W. Stewart, M.D., jws6@columbia.edu The Depression Evaluation Service (DES) is anticipating a new treatment study entitled “Combining Antidepressants to Hasten Remission from Depression.” Prior to the start date a volunteer is needed to put together study books and start-up materials, and otherwise help organize the start-up meetings. Once recruitment begins, they would track patients through the study, input the study data and otherwise help organize and prepare materials for the in-study meetings.

Suzanne Vosburg, Ph.D., skv2001@columbia.edu The Buprenorphine Program at Columbia University is an outpatient program that treats individuals who abuse opioids (heroin, methadone, and prescription pain medications) with Suboxone. Contact persons: Suzanne Vosburg, Ph.D. or Erik Gunderson, M.D. gunders@pi.cpmc.columbia.edu).

Milton Wainberg, M.D., mlw35@columbia.edu Dr. Wainberg is collaborating with researchers, mental health care providers and local departments of health in Brazil to test an intervention to reduce risk behavior among patients with serious mental illness.

Myrna Weissman Ph.D., weissman@childpsych.columbia.edu A student can work on screening for depression in a genetic study of early onset recurrent depression or on analysis of a three generation study of depression looking at the clinical data and integrating it with MRI and genetics data.

Jennifer P. Wisdom, Ph.D., jwisdom@pi.cpmc.columbia.edu Health services research in mental health and drug treatment; recovery processes for individuals with serious mental illness and adolescent co-occurring disorders.  Opportunities available in conducting literature reviews, writing manuscripts and grant proposals, and data analysis.

Dongrong Xu, Ph.D., dx2103@columbia.edu I work in magnetic resonance imaging, in particular diffusion tensor imaging.  We develop methods and algorithms for the analysis of imaging data, and apply the methods to study brain functions and various psychiatric diseases.  I am also interested in scientific visualization and compute virtual reality for assisting brain MRI study.  Students with engineering backgrounds are welcome.